DNB Carnegie Access: Vivesto - Framsteg inom veterinärmedicin


Idag, 17:28

DNB Carnegie intervjuar vd Erik Kinnman om de kliniska framstegen för Paccal Vet inom cancerbehandling för hundar och katter. Vi diskuterar nyligen presenterade resultat, bolagets partneringstrategi samt de värdeskapande händelser som investerare kan se fram emot under de kommande månaderna.

Se intervjun här: https://youtu.be/XxdbmkW79F4

Information
This is a press release from DNB Carnegie. For information about DNB Carnegie commissioned research, see https://access.dnbcarnegie.com/, or contact our commissioned research team at cr@carnegie.se.

About Us
DNB Carnegie is the leading and independent Nordic investment and private bank. Our operations within Corporate Finance, Securities and Research, Private Banking and Wealth Management are among the market leaders within their respective sectors. Together, they build an unbeatable combination of integrated knowledge, guiding our clients towards better business. DNB Carnegie operates in six countries and has more than 800 employees.

Läs mer på MFN



Marknadsöversikt

1 DAG %

Senast

1 mån